- Past Symposiums
- Contact Us
- DSI Home
2021 Event Sponsors & Supporters
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. The company’s non-invasive, sublingual formulation technology is designed to efficiently deliver highly lipophilic drugs with consistent pharmacokinetic profiles. In November of 2018, its lead product candidate DSUVIA™ (sufentanil sublingual tablet 30 mcg) was approved by the U.S. Food and Drug Administration. In the EU, the European Commission has granted marketing approval for DZUVEO (knows in the US as DSUVIA) for use in medically monitored settings. In addition, the company has also received approval for a patient controlled analgesia system (PCA) in the EU, known as Zalviso® (sufentanil sublingual tablet system).
“For more than 25 years, ZOLL® has been a trusted partner delivering acute critical care technologies to the military. ZOLL products are extensively utilized throughout the entire military healthcare system in support of the warfighter and casualty care treatment within all roles of operational En-Route Care System, disaster and humanitarian response. ZOLL’s leading resuscitation and critical care technologies are field-proven in all roles of operational medical care on the battlefield, in aeromedical evacuation and transport, in field hospitals, and in garrison for definitive care. ZOLL technologies are reliable, ready, and trusted to treat our warfighters anywhere on land, sea, or air.”